Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.

Juvenile hyaline fibromatosis (JHF) and infantile systemic hyalinosis (ISH) are autosomal recessive syndromes of unknown etiology characterized by multiple, recurring subcutaneous tumors, gingival hypertrophy, joint contractures, osteolysis, and osteoporosis. Both are believed to be allelic disorders; ISH is distinguished from JHF by its more severe phenotype, which includes hyaline deposits in multiple organs, recurrent infections, and death within the first 2 years of life. Using the previously reported chromosome 4q21 JHF disease locus as a guide for candidate-gene identification, we identified and characterized JHF and ISH disease-causing mutations in the capillary morphogenesis factor-2 gene (CMG2). Although CMG2 encodes a protein upregulated in endothelial cells during capillary formation and was recently shown to function as an anthrax-toxin receptor, its physiologic role is unclear. Two ISH family-specific truncating mutations, E220X and the 1-bp insertion P357insC that results in translation of an out-of-frame stop codon, were generated by site-directed mutagenesis and were shown to delete the CMG-2 transmembrane and/or cytosolic domains, respectively. An ISH compound mutation, I189T, is predicted to create a novel and destabilizing internal cavity within the protein. The JHF family-specific homoallelic missense mutation G105D destabilizes a von Willebrand factor A extracellular domain alpha-helix, whereas the other mutation, L329R, occurs within the transmembrane domain of the protein. Finally, and possibly providing insight into the pathophysiology of these diseases, analysis of fibroblasts derived from patients with JHF or ISH suggests that CMG2 mutations abrogate normal cell interactions with the extracellular matrix.

[1]  John A. Young,et al.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Peter Lonai,et al.  Epithelial mesenchymal interactions, the ECM and limb development , 2003, Journal of anatomy.

[3]  Yuriko Yamagata,et al.  Buried water molecules contribute to the conformational stability of a protein. , 2003, Protein engineering.

[4]  N. Rahman,et al.  The gene for juvenile hyaline fibromatosis maps to chromosome 4q21. , 2002, American journal of human genetics.

[5]  R. Hynes,et al.  Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. , 2002, Molecular biology of the cell.

[6]  D. Gudbjartsson,et al.  A high-resolution recombination map of the human genome , 2002, Nature Genetics.

[7]  J. Engel,et al.  Domain structure and organisation in extracellular matrix proteins. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[8]  J. White,et al.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. , 2001, American journal of human genetics.

[9]  S. Maxwell,et al.  Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. , 2001, Journal of cell science.

[10]  G. Mortier,et al.  Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia , 2001, Nature Genetics.

[11]  M. Stack,et al.  Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase Activity* , 2001, The Journal of Biological Chemistry.

[12]  M. Spycher,et al.  Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature. , 2001, American journal of medical genetics.

[13]  K. Lyons,et al.  Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.

[14]  K. McGowan,et al.  Laminins and human disease , 2000, Microscopy research and technique.

[15]  L. Goldfinger,et al.  Laminins: An overview , 2000, Microscopy research and technique.

[16]  P. Yurchenco,et al.  Form and function: The laminin family of heterotrimers , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  W. Kleijer,et al.  Juvenile Hyaline Fibromatosis: Clinical Heterogeneity in Three Patients , 1999, Dermatology.

[18]  J. Uitto,et al.  Mutation analysis and molecular genetics of epidermolysis bullosa. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[19]  C. Calli,et al.  Two Siblings with Juvenile Hyaline Fibromatosis: Case Reports and Review of the Literature , 1999, Clinical Rheumatology.

[20]  J. Scott,et al.  A frameshift mutation at Gly975 in the transmembrane domain of GPIIb prevents GPIIb-IIIa expression--analysis of two novel mutations in a kindred with type I glanzmann thrombasthenia. , 1998, Thrombosis and haemostasis.

[21]  R. Aurora,et al.  Helix capping , 1998, Protein science : a publication of the Protein Society.

[22]  G. Zambruno,et al.  A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. , 1997, The Journal of clinical investigation.

[23]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[24]  J. Uitto,et al.  Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia , 1995, Nature Genetics.

[25]  G. Martin,et al.  FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations , 1994, Cell.

[26]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[27]  J. Opitz,et al.  Juvenile hyaline fibromatosis: two new patients and review of the literature. , 1987, American journal of medical genetics.

[28]  B. Landing,et al.  Infantile systemic hyalinosis: report of four cases of a disease, fatal in infancy, apparently different from juvenile systemic hyalinosis. , 1986, Pediatric pathology.